Details for Patent: 10,952,997
✉ Email this page to a colleague
Which drugs does patent 10,952,997 protect, and when does it expire?
Patent 10,952,997 protects INGREZZA and is included in one NDA.
This patent has seventy patent family members in eleven countries.
Summary for Patent: 10,952,997
Title: | Methods for the administration of certain VMAT2 inhibitors |
Abstract: | Provided are methods of administering a vesicular monoamine transport 2 (VMAT2) inhibitor chosen from valbenazine and (+)-a-3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]i- soquinolin-2-ol, or a pharmaceutically acceptable salt and/or isotopic variant thereof, to a patient in need thereof wherein the patient is also being administered a strong cytochrome P450 3A4 (CYP3A4) inhibitor. |
Inventor(s): | O'Brien; Christopher F. (San Diego, CA), Bozigian; Haig P. (San Diego, CA) |
Assignee: | Neurocrine Biosciences, Inc. (San Diego, CA) |
Application Number: | 16/870,423 |
Patent Claim Types: see list of patent claims | Use; Dosage form; |
Drugs Protected by US Patent 10,952,997
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Neurocrine | INGREZZA | valbenazine tosylate | CAPSULE;ORAL | 209241-001 | Apr 11, 2017 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | TREATMENT OF TARDIVE DYSKINESIA | ⤷ Try a Trial | ||||
Neurocrine | INGREZZA | valbenazine tosylate | CAPSULE;ORAL | 209241-003 | Apr 23, 2021 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | TREATMENT OF TARDIVE DYSKINESIA | ⤷ Try a Trial | ||||
Neurocrine | INGREZZA | valbenazine tosylate | CAPSULE;ORAL | 209241-002 | Oct 4, 2017 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | TREATMENT OF TARDIVE DYSKINESIA | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,952,997
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2017395700 | ⤷ Try a Trial | |||
Australia | 2017395701 | ⤷ Try a Trial | |||
Australia | 2017395702 | ⤷ Try a Trial | |||
Australia | 2017395703 | ⤷ Try a Trial | |||
Australia | 2017395704 | ⤷ Try a Trial | |||
Australia | 2022203201 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |